Innate immune response to Streptococcus pyogenes depends on the combined activation of TLR13 and TLR2. 2015

Christina Fieber, and Marton Janos, and Tina Koestler, and Nina Gratz, and Xiao-Dong Li, and Virginia Castiglia, and Marion Aberle, and Martina Sauert, and Mareike Wegner, and Lena Alexopoulou, and Carsten J Kirschning, and Zhijian J Chen, and Arndt von Haeseler, and Pavel Kovarik
Max F. Perutz Laboratories, University of Vienna, Vienna, Austria.

Innate immune recognition of the major human-specific Gram-positive pathogen Streptococcus pyogenes is not understood. Here we show that mice employ Toll-like receptor (TLR) 2- and TLR13-mediated recognition of S. pyogenes. These TLR pathways are non-redundant in the in vivo context of animal infection, but are largely redundant in vitro, as only inactivation of both of them abolishes inflammatory cytokine production by macrophages and dendritic cells infected with S. pyogenes. Mechanistically, S. pyogenes is initially recognized in a phagocytosis-independent manner by TLR2 and subsequently by TLR13 upon internalization. We show that the TLR13 response is specifically triggered by S. pyogenes rRNA and that Tlr13-/- cells respond to S. pyogenes infection solely by engagement of TLR2. TLR13 is absent from humans and, remarkably, we find no equivalent route for S. pyogenes RNA recognition in human macrophages. Phylogenetic analysis reveals that TLR13 occurs in all kingdoms but only in few mammals, including mice and rats, which are naturally resistant against S. pyogenes. Our study establishes that the dissimilar expression of TLR13 in mice and humans has functional consequences for recognition of S. pyogenes in these organisms.

UI MeSH Term Description Entries
D007113 Immunity, Innate The capacity of a normal organism to remain unaffected by microorganisms and their toxins. It results from the presence of naturally occurring ANTI-INFECTIVE AGENTS, constitutional factors such as BODY TEMPERATURE and immediate acting immune cells such as NATURAL KILLER CELLS. Immunity, Native,Immunity, Natural,Immunity, Non-Specific,Resistance, Natural,Innate Immune Response,Innate Immunity,Immune Response, Innate,Immune Responses, Innate,Immunity, Non Specific,Innate Immune Responses,Native Immunity,Natural Immunity,Natural Resistance,Non-Specific Immunity
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D010587 Phagocytosis The engulfing and degradation of microorganisms; other cells that are dead, dying, or pathogenic; and foreign particles by phagocytic cells (PHAGOCYTES). Phagocytoses
D010802 Phylogeny The relationships of groups of organisms as reflected by their genetic makeup. Community Phylogenetics,Molecular Phylogenetics,Phylogenetic Analyses,Phylogenetic Analysis,Phylogenetic Clustering,Phylogenetic Comparative Analysis,Phylogenetic Comparative Methods,Phylogenetic Distance,Phylogenetic Generalized Least Squares,Phylogenetic Groups,Phylogenetic Incongruence,Phylogenetic Inference,Phylogenetic Networks,Phylogenetic Reconstruction,Phylogenetic Relatedness,Phylogenetic Relationships,Phylogenetic Signal,Phylogenetic Structure,Phylogenetic Tree,Phylogenetic Trees,Phylogenomics,Analyse, Phylogenetic,Analysis, Phylogenetic,Analysis, Phylogenetic Comparative,Clustering, Phylogenetic,Community Phylogenetic,Comparative Analysis, Phylogenetic,Comparative Method, Phylogenetic,Distance, Phylogenetic,Group, Phylogenetic,Incongruence, Phylogenetic,Inference, Phylogenetic,Method, Phylogenetic Comparative,Molecular Phylogenetic,Network, Phylogenetic,Phylogenetic Analyse,Phylogenetic Clusterings,Phylogenetic Comparative Analyses,Phylogenetic Comparative Method,Phylogenetic Distances,Phylogenetic Group,Phylogenetic Incongruences,Phylogenetic Inferences,Phylogenetic Network,Phylogenetic Reconstructions,Phylogenetic Relatednesses,Phylogenetic Relationship,Phylogenetic Signals,Phylogenetic Structures,Phylogenetic, Community,Phylogenetic, Molecular,Phylogenies,Phylogenomic,Reconstruction, Phylogenetic,Relatedness, Phylogenetic,Relationship, Phylogenetic,Signal, Phylogenetic,Structure, Phylogenetic,Tree, Phylogenetic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012329 RNA, Bacterial Ribonucleic acid in bacteria having regulatory and catalytic roles as well as involvement in protein synthesis. Bacterial RNA
D013297 Streptococcus pyogenes A species of gram-positive, coccoid bacteria isolated from skin lesions, blood, inflammatory exudates, and the upper respiratory tract of humans. It is a group A hemolytic Streptococcus that can cause SCARLET FEVER and RHEUMATIC FEVER. Flesh-Eating Bacteria,Streptococcus Group A,Bacteria, Flesh-Eating
D051193 Toll-Like Receptors A family of pattern recognition receptors characterized by an extracellular leucine-rich domain and a cytoplasmic domain that share homology with the INTERLEUKIN 1 RECEPTOR and the DROSOPHILA toll protein. Following pathogen recognition, toll-like receptors recruit and activate a variety of SIGNAL TRANSDUCING ADAPTOR PROTEINS. Receptors, Toll-Like,Toll-Like Receptor,Receptor, Toll-Like,Receptors, Toll Like,Toll Like Receptor,Toll Like Receptors
D051195 Toll-Like Receptor 2 A pattern recognition receptor that forms heterodimers with other TOLL-LIKE RECEPTORS. It interacts with multiple ligands including PEPTIDOGLYCAN, bacterial LIPOPROTEINS, lipoarabinomannan, and a variety of PORINS. TLR2 Receptor,Receptor, TLR2,Toll Like Receptor 2

Related Publications

Christina Fieber, and Marton Janos, and Tina Koestler, and Nina Gratz, and Xiao-Dong Li, and Virginia Castiglia, and Marion Aberle, and Martina Sauert, and Mareike Wegner, and Lena Alexopoulou, and Carsten J Kirschning, and Zhijian J Chen, and Arndt von Haeseler, and Pavel Kovarik
October 2011, Vaccine,
Christina Fieber, and Marton Janos, and Tina Koestler, and Nina Gratz, and Xiao-Dong Li, and Virginia Castiglia, and Marion Aberle, and Martina Sauert, and Mareike Wegner, and Lena Alexopoulou, and Carsten J Kirschning, and Zhijian J Chen, and Arndt von Haeseler, and Pavel Kovarik
February 2021, The Journal of clinical investigation,
Christina Fieber, and Marton Janos, and Tina Koestler, and Nina Gratz, and Xiao-Dong Li, and Virginia Castiglia, and Marion Aberle, and Martina Sauert, and Mareike Wegner, and Lena Alexopoulou, and Carsten J Kirschning, and Zhijian J Chen, and Arndt von Haeseler, and Pavel Kovarik
May 1996, The Australasian journal of dermatology,
Christina Fieber, and Marton Janos, and Tina Koestler, and Nina Gratz, and Xiao-Dong Li, and Virginia Castiglia, and Marion Aberle, and Martina Sauert, and Mareike Wegner, and Lena Alexopoulou, and Carsten J Kirschning, and Zhijian J Chen, and Arndt von Haeseler, and Pavel Kovarik
October 2006, Journal of leukocyte biology,
Christina Fieber, and Marton Janos, and Tina Koestler, and Nina Gratz, and Xiao-Dong Li, and Virginia Castiglia, and Marion Aberle, and Martina Sauert, and Mareike Wegner, and Lena Alexopoulou, and Carsten J Kirschning, and Zhijian J Chen, and Arndt von Haeseler, and Pavel Kovarik
August 2022, Microbial pathogenesis,
Christina Fieber, and Marton Janos, and Tina Koestler, and Nina Gratz, and Xiao-Dong Li, and Virginia Castiglia, and Marion Aberle, and Martina Sauert, and Mareike Wegner, and Lena Alexopoulou, and Carsten J Kirschning, and Zhijian J Chen, and Arndt von Haeseler, and Pavel Kovarik
May 2014, The Journal of infectious diseases,
Christina Fieber, and Marton Janos, and Tina Koestler, and Nina Gratz, and Xiao-Dong Li, and Virginia Castiglia, and Marion Aberle, and Martina Sauert, and Mareike Wegner, and Lena Alexopoulou, and Carsten J Kirschning, and Zhijian J Chen, and Arndt von Haeseler, and Pavel Kovarik
June 2022, mBio,
Christina Fieber, and Marton Janos, and Tina Koestler, and Nina Gratz, and Xiao-Dong Li, and Virginia Castiglia, and Marion Aberle, and Martina Sauert, and Mareike Wegner, and Lena Alexopoulou, and Carsten J Kirschning, and Zhijian J Chen, and Arndt von Haeseler, and Pavel Kovarik
January 2021, Frontiers in cellular and infection microbiology,
Christina Fieber, and Marton Janos, and Tina Koestler, and Nina Gratz, and Xiao-Dong Li, and Virginia Castiglia, and Marion Aberle, and Martina Sauert, and Mareike Wegner, and Lena Alexopoulou, and Carsten J Kirschning, and Zhijian J Chen, and Arndt von Haeseler, and Pavel Kovarik
February 2007, Immunology letters,
Christina Fieber, and Marton Janos, and Tina Koestler, and Nina Gratz, and Xiao-Dong Li, and Virginia Castiglia, and Marion Aberle, and Martina Sauert, and Mareike Wegner, and Lena Alexopoulou, and Carsten J Kirschning, and Zhijian J Chen, and Arndt von Haeseler, and Pavel Kovarik
August 2020, Cells,
Copied contents to your clipboard!